Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Malignant Melanoma

  Free Subscription


23.03.2026

2 Am J Dermatopathol
1 Am J Ophthalmol
2 Ann Surg Oncol
1 BMC Cancer
2 Br J Dermatol
3 Cancer
1 Cancer Lett
1 Cancer Res
1 Clin Cancer Res
1 Int J Cancer
1 J Am Acad Dermatol
1 J Immunol
1 J Invest Dermatol
1 Melanoma Res
1 Ophthalmology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. GHALI H, Al-Bzour AN, Boby A, Aflatooni S, et al
    Associations Between Pigmentation and the Clinicopathologic and Immune Landscape of Melanoma.
    Am J Dermatopathol. 2026 Mar 20. doi: 10.1097/DAD.0000000000003223.
    PubMed         Abstract available

  2. SHORE KT, Mochel MC, Karpinski P, Sepehr A, et al
    Clinicopathologic and Molecular Analyses of 2 Basomelanocytic Tumors and Literature Review.
    Am J Dermatopathol. 2026;48:318-326.
    PubMed         Abstract available


    Am J Ophthalmol

  3. LISHINSKY-FISCHER N, Gharra S, Nitzan I, Chowers I, et al
    Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Propensity-Matched Cohort Study.
    Am J Ophthalmol. 2026;284:153-160.
    PubMed         Abstract available


    Ann Surg Oncol

  4. HERB J, Bassett RL, Torres-Cabala CA, Prieto VG, et al
    Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.
    Ann Surg Oncol. 2026 Mar 16. doi: 10.1245/s10434-026-19130.
    PubMed         Abstract available

  5. MOR E, Apte S, Bressel M, Broman KK, et al
    ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial.
    Ann Surg Oncol. 2026 Mar 16. doi: 10.1245/s10434-026-19430.
    PubMed        


    BMC Cancer

  6. WU M, Larkin J, Furness A, Stavropoulou C, et al
    The cost-effectiveness of tumour-infiltrating lymphocyte cell therapy for advanced melanoma: a systematic review.
    BMC Cancer. 2026 Mar 20. doi: 10.1186/s12885-026-15888.
    PubMed        


    Br J Dermatol

  7. KAHLER S, Yan S, Mothershaw A, Leo F, et al
    Automated classification of site-specific cutaneous photodamage using a convolutional neural network and 3D total body photography.
    Br J Dermatol. 2025 Dec 10:ljaf516. doi: 10.1093.
    PubMed         Abstract available

  8. LYNGSTRAND JE, Rossell EL, Bonnelykke-Behrndtz ML, Laurberg T, et al
    The impact of type 2 diabetes on sex- and stage-specific melanoma recurrence and mortality: A Danish cohort study, 2004 to 2024.
    Br J Dermatol. 2026 Mar 15:ljag097. doi: 10.1093.
    PubMed         Abstract available


    Cancer


  9. Correction to "Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele".
    Cancer. 2026;132:e70350.
    PubMed        

  10. DESSINIOTI C, Stratigos A
    Neoadjuvant systemic immunotherapy for skin cancers.
    Cancer. 2026;132:e70354.
    PubMed         Abstract available

  11. FIELDS BC, Traweek RS, Jiang K, Witt RG, et al
    High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerability.
    Cancer. 2026;132:e70335.
    PubMed         Abstract available


    Cancer Lett

  12. RUMNIEKS F, Vainshelbaum NM, Salmina K, Lazovska M, et al
    Resistance of BRAF(V600E)-mutant melanoma to Vemurafenib: a senescence-induced swing from differentiation to blastulation followed by proliferation.
    Cancer Lett. 2026 Mar 12:218430. doi: 10.1016/j.canlet.2026.218430.
    PubMed         Abstract available


    Cancer Res

  13. HU J, Zhang B, Chen J, Huang G, et al
    Cortactin Suppresses mTOR-Dependent Senescence in Circulating Tumor Cells.
    Cancer Res. 2026;86:1351-1371.
    PubMed         Abstract available


    Clin Cancer Res

  14. NINMER EK, Zhu H, Sarkar A, Chianese-Bullock KA, et al
    Impact of GM-CSF and two-site vaccination on clinical outcomes after multipeptide vaccination for melanoma: long-term analysis of a randomized phase II trial.
    Clin Cancer Res. 2026 Mar 18. doi: 10.1158/1078-0432.CCR-25-4606.
    PubMed         Abstract available


    Int J Cancer

  15. GUTZMER R, Weichenthal M, Eigentler T, Mohr P, et al
    Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.
    Int J Cancer. 2026 Mar 15. doi: 10.1002/ijc.70440.
    PubMed         Abstract available


    J Am Acad Dermatol

  16. HUHMANN LB, Hwang JC, Kim DY, Nannini K, et al
    Frailty and survival outcomes in veterans with invasive cutaneous melanoma: A Veterans Affairs Cancer Registry retrospective cohort study.
    J Am Acad Dermatol. 2026 Mar 12:S0190-9622(26)00395.
    PubMed        


    J Immunol

  17. ONCUL S, Lee H, Singh S, Yee C, et al
    B cell depletion promotes melanoma tumor growth in a CD4+ T cell-dependent manner.
    J Immunol. 2026;215:vkag004.
    PubMed         Abstract available


    J Invest Dermatol

  18. CHEN YH, Liau JY, Tsai JF, Liao YH, et al
    Spatial Lipidomics-based Melanoma Diagnostics by Integration of Mass Spectrometry Imaging and Machine Learning.
    J Invest Dermatol. 2026 Mar 17:S0022-202X(26)00963.
    PubMed         Abstract available


    Melanoma Res

  19. YOON U, Wang J, Covelens Z
    Percutaneous hepatic perfusion with melphalan in liver metastatic uveal melanoma and viscoelastic hemostatic assays guided coagulation assessment for thrombocytopenia.
    Melanoma Res. 2026 Mar 16. doi: 10.1097/CMR.0000000000001093.
    PubMed         Abstract available


    Ophthalmology

  20. FARRELL LC, Parekh BJ, Milman T
    Pigmented Fungal Colonization of Contact Lens Mimicking Corneal Melanoma.
    Ophthalmology. 2026 Mar 19:S0161-6420(26)00128.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum